Reference group
Sponsors
Alvogen Korea, Abbott Nutrition, McMaster University, Darma Inc., Centro Hospitalar de Lisboa Central
Conditions
BioequivalenceColicGastro-Intestinal ToleranceGastrointestinal ToleranceInsufficient Breast Milk SyndromeParasitic diseasePostmenopausal Women With OsteoporosisPremature Birth
Phase 1
Phase 3
Unknown Phase
Gastrointestinal Tolerance of Infant Formula
CompletedNCT02322138
Start: 2015-01-31End: 2015-06-30Updated: 2015-07-23
Effect of a Prebiotic on Colic and Crying and Fussing Behaviour in Infants
TerminatedNCT02586558
Start: 2017-12-13End: 2019-08-15Updated: 2019-08-28
Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients
CompletedNCT03257956
Start: 2017-08-02End: 2017-09-20Updated: 2019-04-16
Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients Patients
CompletedNCT03269643
Start: 2017-09-01End: 2017-11-24Updated: 2019-04-16
Growth and Tolerance of Infants Fed Milk-Based Infant Formula
CompletedNCT03967132
Start: 2019-06-08End: 2020-05-29Updated: 2020-09-22
Comparative Bioequivalence of Albendazole Tablets of Fidson Healthcare PLC with Zentel® Tablets of GSK in healthy, adult male and female participants under fed conditions.
Active, not recruitingPACTR202411565966953
Start: 2025-01-01Target: 93Updated: 2026-01-27
Domperidone on the Composition of Preterm Breastmilk Using a Human Milk Mid-infrared Spectroscopy Analyzer
Enrolling by invitationNCT06830226
Start: 2025-01-08End: 2025-08-30Target: 81Updated: 2025-03-18